[ON THE PROBLEMS OF THE EXOCRINE PANCREATIC REACTION FOLLOWING INTRAVENOUS TOLBUTAMIDE ADMINISTRATION IN PERSONS WITH NORMAL METABOLISM AND DIABETICS].
D000681:Amylases; D001786:Blood Glucose; D002268:Carboxypeptidases; D003920:Diabetes Mellitus; D003933:Diagnosis; D004381:Duodenal Ulcer; D004798:Enzymes; D005756:Gastritis; D006505:Hepatitis; D006801:Humans; D007275:Injections, Intravenous; D007419:Intestinal Secretions; D010179:Pancreas; D010437:Peptic Ulcer; D010600:Pharmacology; D013276:Stomach Ulcer; D014044:Tolbutamide
D001786:Blood Glucose; D004798:Enzymes; D014044:Tolbutamide; D000681:Amylases; D002268:Carboxypeptidases
AMYLASE; BLOOD SUGAR; CARBOXYPEPTIDASES; DIABETES MELLITUS; DIAGNOSIS; DUODENAL ULCER; ENZYMES; GASTRITIS; HEPATITIS; INJECTIONS, INTRAVENOUS; INTESTINAL SECRETIONS; PANCREAS; PEPTIC ULCER; PHARMACOLOGY; STOMACH ULCER; TOLBUTAMIDE
ZUR PROBLEMATIK DER EXOKRINEN PANKREASREAKTION NACH INTRAVENOESER  TOLBUTAMID-BELASTUNG BEI STOFFWECHSELGESUNDEN UND DIABETIKERN.